We assessed the effect of two different doses of alfentanil (5 and 10 µg.kg -1 ) on the conditions for laryngeal mask airway insertion in ASA 1 and 2 patients who received propofol for induction of anaesthesia. One hundred and fifty unpremedicated patients were randomly allocated to receive either propofol 2.5 mg.kg -1 only (Group P), alfentanil 5 µg.kg -1 and propofol 2.5 mg.kg -1 (Group A5), or alfentanil 10 µg.kg -1 and propofol 2.5 mg.kg -1 (Group A10). The addition of alfentanil to propofol resulted in a greater ease of insertion and a better quality of airway patency. Pretreatment with alfentanil also resulted in a significantly higher success rate during the first attempt at inserting the laryngeal mask airway compared with Group P (Group P 58%, Group A5 96%, Group A10 94%). Patients in Group P were apnoeic for a mean(±SD) time of 3.3(±1.9) min, 4.71(±2.2) min in Group A5, and 7.32(±4.3) min in Group A10. The use of alfentanil 10 µg.kg -1 with propofol, however, led to a significant decrease in mean arterial pressure and heart rate. We concluded that pretreatment with intravenous alfentanil 5 µg.kg -1 prior to propofol provides excellent conditions for insertion of laryngeal mask with minimal adverse haemodynamic changes.
Propofol is the induction agent most commonly used to facilitate insertion of a laryngeal mask airway (LMA). When used alone in unpremedicated patients however, undesirable responses such as gagging and coughing may occur 1 . Alfentanil, with its rapid onset and short duration of action, may be a logical choice for augmenting propofol during anaesthesia. The use of the two drugs has been shown to improve intubating conditions and attenuate the cardiovascular response to intubation without neuromuscular blockade 2, 3 . In this study we aimed to evaluate the use of alfentanil to facilitate LMA insertion following induction of anaesthesia with propofol.
METHOD
We investigated 150 unpremedicated ASA 1 and 2 patients, aged 21 to 60 years, scheduled for elective operations during which a general anaesthesia with an LMA was appropriate. Hospital Ethics Committee approval and informed consent were obtained. Patients were excluded if they were receiving antiepileptic medication, if there was a history of gastric reflux, if their body weight was 30% outside the normal weight for height or if a difficult airway was anticipated.
Using sealed envelopes, the patients were randomly allocated to one of three groups. After three minutes' preoxygenation, the patients in the control group, Group P, received propofol 2.5 mg.kg -1 . Group A5 patients received alfentanil 5 µg.kg -1 followed one minute later by propofol 2.5 mg.kg -1 . Group A10 patients received alfentanil 10 µg.kg -1 followed one minute later by propofol 2.5 mg.kg -1 . One minute after propofol was administered, the LMA was inserted by another anaesthetist who was blinded to the induction drugs used, using the insertion technique as described by Brain 4 . The same anaesthetist (SA), who had successfully inserted the LMA in more than 200 patients performed the laryngeal mask insertion in all the patients in this study. Following successful LMA insertion, anaesthesia was maintained with 0.5% isoflurane and 70% nitrous oxide in oxygen. The position of the LMA was checked by observing chest movement and capnography. Patients who were apnoeic were manually ventilated to maintain a pulse oximetry reading of >95% and the end-tidal carbon dioxide level of 35 to 40 mmHg. The duration of apnoea was recorded as the time from induction until the first spontaneous breath.
The following conditions were assessed by one of the other investigators (CKF or NTI). Ease of insertion was graded according to a three-point scale. Grade 1-excellent, no response to laryngeal mask insertion; Grade 2-acceptable; gagging or swallowing with insertion of laryngeal mask; Grade 3-poor; unable to open mouth or biting on insertion of laryngeal mask. The quality of the airway was assessed on a two-point scale and equated to proper positioning of the laryngeal mask. Airway quality was graded as Good-easy ventilation or Poor-partial or complete obstruction.
Another dose of propofol 0.5 mg.kg -1 bolus was given if the patient had airway reflexes preventing laryngeal mask insertion or limb and head movement requiring restraint. Another attempt at LMA insertion was made after 30 seconds and the cycle repeated till the LMA was successfully inserted. The number of attempts at insertion was recorded, but the ease of insertion and airway quality was only assessed during the first attempt at LMA insertion. Bradycardia, defined as heart rate less than 50 beats per minute, was treated with an intravenous bolus of atropine 0.3 to 0.6 mg.
Non-invasive blood pressure, heart rate, electrocardiogram, capnography and oxygen saturation were monitored during induction of anaesthesia and laryngeal mask insertion. These parameters were recorded every minute. Data were analyzed using Chi square test for categorical variables and Kruskall Wallis test where appropriate. Level of significance was taken at P<0.05.
RESULTS
Demographic data are shown in Table 1 . The treatment and control groups were of similar age, weight and gender ratio. None of the patients suffered any serious adverse events during the study. The laryngeal mask airway was successfully inserted in all patients, although three attempts at insertion were required in some. We found that the addition of alfentanil (Groups A5 and A10) significantly increased the ease and success of laryngeal mask insertion compared to patients given propofol alone (Group P) ( Table 2 and 3). The effect is dosedependent with a greater ease achieved at the higher dose of alfentanil. No significant difference was found in the grade of the airway obtained in patients who had the laryngeal mask inserted successfully at the first attempt ( Table 2) .
Additional propofol was required for successful insertion of the laryngeal mask airway in 62% of patients in Group P, 28% in Group A5, and 10% in Group A10.
The resumption of spontaneous respiration from induction was significantly different in all three groups ( Table 3 ). The duration of apnoea in Group P was 3.3±4.7 minutes, while that of Groups A5 and A10 was significantly longer at 4.7±2.2 and 7.3±4.3 minutes respectively. The duration of Group A10 was also statistically significantly longer than that of Group A5. Baseline heart rates were similar between groups ( Table 4 ). Patients in Group P had a slight increase in pulse rate after insertion of laryngeal mask that was statistically significant from the first to the third minute. Patients in the other two groups however, experienced a decrease in heart rate. Seven out of the 50 patients in Group A10 had heart rates of less than 50/min and required atropine 0.3 mg as rescue therapy.
After induction and insertion of the laryngeal mask airway, the mean blood pressure decreased by 16 to 20% when compared to the baseline values. The greatest decrease was in Group A10 where the mean blood pressure had dropped from 90 to 69 mmHg in the third minute post-LMA insertion. The decreases were still within clinically acceptable limits. 
DISCUSSION
Our data showed that propofol 2.5 mg/kg, pretreated with alfentanil 5 or 10 µg/kg, reliably allowed insertion of a laryngeal mask airway. In contrast to other studies 1, [5] [6] [7] , our data showed that excellent conditions for insertion of the laryngeal mask were very low (10% of the 50 patients in this group) when the patients were induced with intravenous propofol alone, with almost 60% of patients requiring an additional bolus of propofol for successful insertion of the LMA. This is probably due to the lack of benzodiazepine premedication or other adjuvant such as intravenous fentanyl given concomitantly at induction, as reported in the other studies.
We consider that propofol is superior to thiopentone when a laryngeal mask airway is to be inserted at induction of general anaesthesia 1, 5 . Alfentanil has been used together with propofol, with considerable success, to facilitate intubation without muscle relaxant and it is thus not surprising that the combination significantly improves the ease and success of insertion of laryngeal mask compared with propofol alone. The higher success rate when the two drugs are used together is probably due to the additive effect incorporating the analgesic and anti-tussive effects of the opioid. The success rate in our study is higher than those obtained with the use of topical or intravenous lignocaine as an adjuvant 6, 8 , the use of opioid 9 and benzodiazepine premedication 10 and close to the success provided by the use of midazolam at induction combined with propofol 11, 12 .
Both doses of alfentanil prevented the usual rise in the blood pressure and heart rate related to insertion of a laryngeal mask that was present in the control group. The decrease in the mean arterial pressure relative to baseline values and heart rate subsequently is not unexpected in patients maintained under volatile-based anaesthesia without surgical stimulation. The decrease at the third minute post-induction in the mean arterial pressure relative to baseline values of 16% in the control group, 19% in the patients given 5 µg.kg -1 alfentanil and 20% in those patients given 10 µg.kg -1 alfentanil is however, well tolerated in this group of healthy, well hydrated patients. No patient required vasopressors for hypotension during the induction period.
The decrease in heart rate post-induction was greatest in the group given 10 µg.kg -1 alfentanil, with a 10% decrease at the third minute post-induction. Seven patients in this group developed bradycardia of 42 to 44/minute and required atropine 0.3 mg. Patients given 5 µg/kg alfentanil had a relatively stable heart rate with a maximal decrease of 5% from baseline values, a change that is clinically insignificant.
While rigidity has been reported with the use of potent opioids, this did not occur with any of our patients. However, prolonged apnoea may be a problem in patients given the higher dose of alfentanil. The duration of apnoea in the patients given 10 µg.kg -1 alfentanil is almost twice as long as those in the control group given propofol alone; in fact two of the patients in the A10 group had a return of spontaneous respiration only after nearly 20 minutes, despite the start of the surgical procedure. In most of the patients studied however, we found that the short duration of apnoea was not a clinical problem.
While there are other studies of a similar nature advocating the use of muscle relaxants (depolarizers and nondepolarizers) to facilitate the insertion of a laryngeal mask, we considered that the usage of such relaxants might lead to potential problems such as myalgia, masseter spasm, malignant hyperthermia in the case of succinylcholine, or prolonged apnoea, and a delay in recovery with the use of nondepolarizers 13 .
CONCLUSION
We found the addition of alfentanil during induction of anaesthesia with propofol significantly improved conditions for laryngeal mask insertion. At the two doses of alfentanil studied, the use of alfentanil 5 µg.kg -1 with propofol 2.5 mg.kg -1 resulted in similar conditions when compared to the higher dose of alfentanil with the advantages of a shorter duration of apnoea and less hemodynamic changes.
